Japan· JP-3119001M2027
エトレチナート
A etretinate product containing エトレチナート, registered in Japan by 太陽ファルマ, on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Etretinate is registered in 2 of 19 countries.
Countries holding a registration under ATC D05BB01 (etretinate), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 1 of them publish a price we can compare per daily dose
Etretinate · ATC D05BB01
2 / 19 countries
- Finlandprice
- Japan
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- エトレチナート
- Manufacturer
- 太陽ファルマ
- Country
- Japan (JP)
- ATC code
- D05BB01
- ATC class
- Etretinate
- Defined daily dose
- 35 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under D05BB01
Etretinate, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/75c65258-9d11-46ea-8ba5-9ca843567618 GET /v1/drugs/75c65258-9d11-46ea-8ba5-9ca843567618?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２５ｍｇ１カプセル",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3119001M2027",
"category": "内用薬",
"price_yen": 1113.2,
"generic_name": "エトレチナート",
"product_name_jp": null,
"therapeutic_class": "3119",
"transitional_expiry": null
}See everything about etretinate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.